Genprex to focus its clinical efforts on Oncoprex in combination therapy with Osimertinib for NSCLC

Genprex will focus its clinical efforts on Oncoprex in combination therapy with Osimertinib for NSCLC (Credit: PublicDomainPictures from Pixabay)